ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
Piisamirotta
|
49 |
34K |
25 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
49
|
34K
|
25
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
Piisamirotta
|
49 |
34K |
55 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
49
|
34K
|
55
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Piisamirotta
|
304 |
135K |
54 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
304
|
135K
|
54
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Piisamirotta
|
14K |
7.0M |
13 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
14K
|
7.0M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
Piisamirotta
|
104 |
60K |
9 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
104
|
60K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
IMU product line - CF33
|
|
Piisamirotta
|
48 |
24K |
14 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
48
|
24K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
IMU product line - CF33
|
|
Piisamirotta
|
48 |
24K |
22 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
48
|
24K
|
22
|
|